Features of aflibercept plus hyperbaric oxygen therapy for diabetic macular edema
Background: Diabetes mellitus (DM) is a disease characterized by chronic hyperglycemia and a cascade of pathological vascular alterations leading to diabetic retinopathy (DR) and diabetic macular edema (DME). Purpose: To compare clinical characteristics in patients treated with aflibercept only and...
Saved in:
Main Authors: | V. O. Drozdov (Author), V. M. Sakovych (Author) |
---|---|
Format: | Book |
Published: |
Ukrainian Society of Ophthalmologists,
2022-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in clinical and biochemical characteristics in combination treatment for diabetic macular edema
by: V. O. Drozdov, et al.
Published: (2022) -
The role of aflibercept in the management of diabetic macular edema
by: Chang AA, et al.
Published: (2015) -
The efficacy and safety of aflibercept and conbercept in diabetic macular edema
by: Cai S, et al.
Published: (2018) -
Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
by: A. E. Cheberda, et al.
Published: (2018) -
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective
by: Régnier SA, et al.
Published: (2015)